Literature DB >> 10678288

Renal responses to AT1 receptor blockade.

L G Navar1, L M Harrison-Bernard, J D Imig, L Cervenka, K D Mitchell.   

Abstract

Because of the importance of the renin-angiotensin system in the pathophysiology of hypertension and in mediating associated alterations in renal function, angiotensin II (Ang II) AT1 receptor blockers provide a direct means of protecting against influences of excessive Ang II levels. The kidney is an important site of action of Ang II AT1 receptor blockers because intrarenal Ang II not only vasoconstricts the renal vasculature but also reduces sodium excretion and suppresses the pressure natriuresis relationship. Even in normal conditions, intrarenal Ang II content is greater than can be explained on the basis of circulating Ang II and is compartmentalized with proximal tubule concentrations of Ang I and Ang II being several times higher than plasma concentrations. The localization of angiotensinogen in proximal tubule cells further supports the concept that the proximal tubule secretes Ang II or precursors of Ang II into the tubular fluid to activate luminal Ang II receptors. Recent immunohistochemical studies have demonstrated an abundance of AT1 receptors on the luminal surface of proximal and distal tubule cells as well as on vascular smooth muscle cells of afferent and efferent arterioles and on glomerular mesangial cells. Activation of luminal AT1 receptors stimulates the sodium hydrogen exchanger and increases reabsorption rate. The prominence of AT1 receptors in vascular and epithelial tissues in the kidney provides the basis for the powerful effects of AT1 receptor blockers on renal function especially in hypertensive conditions. In the two-kidney, one-clip (2K1C) Goldblatt hypertensive rat model, the nonclipped kidney is renin depleted but the intrarenal Ang II levels are not suppressed and Ang II concentrations in proximal tubular fluid remain high (10(-8) mol/L). AT1 receptor blockers such as candesartan have been shown to cause significant increases in glomerular filtration rate, renal blood flow and proportionately much greater increases in sodium excretion and fractional sodium excretion. Ang II blockade also markedly increases the slope of the pressure natriuresis relationship. The collective actions of Ang II blockers on tubular transport and renal hemodynamics provide long-term effects to regulate sodium balance, which contributes to the long-term control of hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678288     DOI: 10.1016/s0895-7061(99)00248-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

1.  Angiotensin II stimulates thick ascending limb superoxide production via protein kinase C(α)-dependent NADPH oxidase activation.

Authors:  Marcela Herrera; Guillermo B Silva; Jeffrey L Garvin
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

2.  Modulating Role of Ang1-7 in Control of Blood Pressure and Renal Function in AngII-infused Hypertensive Rats.

Authors:  Marta Kuczeriszka; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Minolfa C Prieto; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2018-03-10       Impact factor: 2.689

Review 3.  Role of stimulated intrarenal angiotensinogen in hypertension.

Authors:  Ryousuke Satou; Weijian Shao; L Gabriel Navar
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-05-18

4.  ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells.

Authors:  Kayoko Miyata; Ryousuke Satou; Weijian Shao; Minolfa C Prieto; Maki Urushihara; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

Review 5.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

6.  Intratubular Renin-Angiotensin System in Hypertension.

Authors:  Yuki Suzaki; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori
Journal:  Curr Hypertens Rev       Date:  2006

Review 7.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats.

Authors:  Amanda K Stennett; Xiaoying Qiao; Anthony E Falone; Vera V Koledova; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-16       Impact factor: 4.733

Review 9.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Vascular control of kidney epithelial transporters.

Authors:  Matthew A Sparks; Emre Dilmen; Donna L Ralph; Fitra Rianto; Thien A Hoang; Alison Hollis; Edward J Diaz; Rishav Adhikari; Gabriel Chew; Enrico G Petretto; Susan B Gurley; Alicia A McDonough; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.